Results 1 to 10 of about 32,822 (166)

DURATION OF DUAL ANTIPLATELET THERAPY

Атеротромбоз, 2016
The review article updates on the key challenge in the present-day cardiology duration of dual antiplatelet  therapy (DAPT) in patients with a history of acute coronary syndrome.
O. L. Barbarash
doaj   +3 more sources

Dual Antiplatelet Therapy in Coronary Artery Disease [PDF]

Cardiology and Therapy, 2020
Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events.
Raghav Sharma, Prathap Kumar, S. P. Prashanth, Yogesh Belagali   +3 more
doaj   +3 more sources

Validation of the Asian-Dual Antiplatelet Therapy Score. [PDF]

Korean Circ J
An individualized approach is recommended for prescribing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Asian-DAPT (ADAPT) scores were developed to assess both ischemic and bleeding risks in Asian populations. This study aimed to validate the ADAPT scores for predicting ischemic and bleeding events in patients ...
Go YH, Kang J, Yun J, Song JE, Hwang D, Han JK, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS.   +10 more
europepmc   +3 more sources

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis

Frontiers in Neurology, 2022
IntroductionConcern over the potential severe bleeding risk of dual antiplatelet therapy for patients with minor stroke after intravenous thrombolysis (IVT) leads to different antiplatelet strategies in the secondary prevention of stroke.
Zhaohan Xu, Nihong Chen, Nihong Chen, Huiling Sun, Teng Jiang, Qiwen Deng, Junshan Zhou, Yingdong Zhang   +7 more
doaj   +1 more source

Advances in Intensified Antithrombotic Therapies in Acute Coronary Syndrome [PDF]

Zhongguo quanke yixue, 2023
Acute coronary syndrome (ACS) is a serious coronary heart disease with relatively high mortality, and a history of ACS is associated with subsequent risk of recurrent ischemic events such as ischemic stroke and myocardial infarction. Platelet aggregation
DENG Tianhua, HUANG Lin, YOU Zhigang
doaj   +1 more source

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy

Frontiers in Cardiovascular Medicine, 2021
Background: Patients using dual antiplatelet therapy after percutaneous coronary intervention are at risk for bleeding. It is currently unknown whether thrombin generation can be used to identify patients receiving dual antiplatelet therapy with ...
C. P. D. M. de Breet, C. P. D. M. de Breet, S. Zwaveling, S. Zwaveling, M. J. A. Vries, R. G. van Oerle, Y. M. C. Henskens, A. W. J. van't Hof, A. W. J. van't Hof, P. E. J. van der Meijden, L. Veenstra, H. ten Cate, H. ten Cate, R. H. Olie, R. H. Olie   +14 more
doaj   +1 more source

Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review

Interventional Cardiology: Reviews, Research, Resources, 2023
Percutaneous coronary intervention with stent implantation is an integral aspect of minimally interventional cardiac procedures. The technology and techniques behind stent design and implantation have evolved rapidly over several decades.
Kevin S Tang, Shoujit Banerjee, George Tang, Pranav M Patel, Antonio H Frangieh   +4 more
doaj   +1 more source

The Risk of Perioperative Bleeding in Patients with Dual Antiplatelet Therapy

Український журнал серцево-судинної хірургії, 2021
Background. Patients with dual antiplatelet therapy have high risk of perioperative bleeding. In this article we evaluated the risk of bleeding in patients whose antiplatelet therapy had not been canceled before coronary artery bypass grafting (CABG).
Taras M. Domanskyy, Artur V. Gabriyelyan, Oleg V. Beregovoy, Stanislav I. Filianin, Svitlana S. Moshta   +4 more
doaj   +1 more source

Gastrointestinal Complications of Dual Antiplatelet Therapy [PDF]

Circulation, 2006
Case presentation: A 59-year-old man with a history of hypertension, dyslipidemia, and smoking was hospitalized with acute coronary syndrome requiring emergency percutaneous coronary intervention with 4 drug-eluting stents. His discharge medications included dual antiplatelet therapy with aspirin 325 mg/d and clopidogrel 75 mg/d.
Neelima G, Vallurupalli, Samuel Z, Goldhaber   +1 more
openaire   +2 more sources

Analysis of Platelet Function from Thromboelastography Examination in Patients with Single and Multiple Antiplatelet Therapy after Percutaneous Coronary Intervention at Dr. Saiful Anwar Malang

Research Journal of Life Science, 2020
Each year, approximately 3 million people with coronary heart disease worldwide undergo percutaneous coronary intervention (PCI). Dual antiplatelet therapy (DAPT) with aspirin and P2Y12 inhibitors became the primary therapy for 6-12 months after PCI ...
Sasmojo Widito, Dadang Hendrawan, Dedy Irawan   +2 more
doaj   +1 more source